Roche Holding AG (ROG) Price & Analysis

Compare

33 Followers

ROG Stock Chart & Stats

Day’s Range― - ―

52-Week RangeCHF231.90 - CHF313.80

Previous CloseN/A

Volume284.04K

Average Volume (3M)933.35K

Market Cap

$219.95B

Enterprise ValueCHF232.87B

Total Cash (Recent Filing)$17.32B

Total Debt (Recent Filing)$36.35B

Price to Earnings (P/E)23.1

Beta1.19

Next Earnings

Jan 29, 2026

EPS Estimate

8.58

Last Dividend Ex-Date

Mar 27, 2025

Dividend Yield3.59%

Share Statistics

EPS (TTM)11.08

Shares Outstanding702,562,700

10 Day Avg. Volume1,039,835

30 Day Avg. Volume933,345

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap1.06

Enterprise Value/Revenue3.79

Enterprise Value/Gross Profit5.12

Enterprise Value/Ebitda14.11

Forecast

1Y Price Target

$271.45

Price Target Upside0.50% Upside

Rating ConsensusHold

Number of Analyst Covering11

Bulls Say, Bears Say

Bulls Say

Earnings PerformanceQ2 sales beat consensus by 1%, driven by a stronger Pharmaceuticals performance.

Market ExpansionRoche announced a $50 billion investment in the US for Pharma and diagnostics, which includes research and development sites and new manufacturing facilities.

Product PerformancePhesgo was 19% above consensus, accounting for 41% of the group sales beat on better demand in China and the US.

Bears Say

CompetitionLonger-term growth appears challenged due to potential branded and biosimilar competition, which is likely to increase.

Regulatory And Safety IssuesRecent safety and regulatory setbacks for key new launches contribute to downside risk for earnings expectations.

Sales PerformanceVabysmo missed consensus by 8% due to lower reimbursement by US charities.

Roche Holding AG News

Advertising, drugmaker stocks in spotlight as Trump moves to regulate pharma ads

Shares of several pharmaceutical makers as well as those of major advertising agencies are in the spotlight on...

4h ago

AZN

Omnicom, WPP under pressure after Trump moves to regulate pharma ads

Shares of Omnicom (OMC) and WPP (WPP) are under pressure after President Trump signed a memorandum mandating pharma...

6h ago

AZN

BMY

Trump Trade: U.S. President signs new pharma order

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by...

6h ago

AZN

Trump signs memorandum mandating pharma ads give more info on risks

U.S. President Donald Trump has signed a memorandum mandating that pharmaceutical advertisements increase the amount of information regarding...

22h ago

AZN

BMY

Alnylam price target raised to $470 from $450 at BMO Capital

BMO Capital raised the firm’s price target on Alnylam (ALNY) to $470 from $450 and keeps an Outperform...

2d ago

ALNY

CHRO

Genentech announces data from AVONELLE-X, SALWEEN studies of Vabysmo

Genentech, a member of Roche (RHHBY), announced new data from the AVONELLE-X and SALWEEN studies of Vabysmo, presented...

5d ago

CHRO

Roche receives EU CE mark for its Port Delivery Platform containing Susvimo

Roche (RHHBY) announced that it has received the EU CE mark for its Port Delivery Platform containing Susvimo,...

6d ago

CHRO

Oppenheimer says Olema collaboration with Pfizer could lead to bidding war

Oppenheimer analyst Matthew Biegler says the firm had a chance to speak with Olema Oncology (OLMA) management after...

7d ago

NVS

PFE

Roche, Alnylam to initiate Phase 3 cardiovascular outcomes trial of zilebesiran

Roche (RHHBY) and Alnylam (ALNY) announced the decision to initiate a Phase 3 cardiovascular outcomes trial to evaluate...

11d ago

ALNY

CHRO

Adaptive Biotechnologies down 5% after Genentech pact terminated

Shares of Adaptive Biotechnologies (ADPT) are down 60c, or 5%, to $12.44 after the company disclosed in a...

23d ago

ADPT

CHRO

Roche Holding AG Faces Growth Challenges Amidst Competition and Regulatory Risks, Downgraded to Underweight

Morgan Stanley analyst Sarita Kapila downgraded the rating on Roche Holding AG to a Sell today, setting a...

1M ago

CHRO

Roche Reports Strong Sales Growth in H1 2025

Roche Holding ( ($RHHVF) ) has released its Q2 earnings. Here is a breakdown of the information Roche...

2M ago

Roche Holding AG: Hold Rating Amid Mixed Financial Signals and Strategic Challenges

Analyst Sarita Kapila of Morgan Stanley maintained a Hold rating on Roche Holding AG, retaining the price target...

2M ago

CHRO

Roche Holding AG: Mixed Q1’25 Results and Strategic U.S. Investments Justify Hold Rating

Morgan Stanley analyst Sarita Kapila has maintained their neutral stance on RHHVF stock, giving a Hold rating today....

5M ago

CHRO

ROG FAQ

What was Roche Holding AG’s price range in the past 12 months?

Roche Holding AG lowest stock price was CHF231.90 and its highest was CHF313.80 in the past 12 months.

What is Roche Holding AG’s market cap?

Roche Holding AG’s market cap is $219.95B.

When is Roche Holding AG’s upcoming earnings report date?

Roche Holding AG’s upcoming earnings report date is Jan 29, 2026 which is in 141 days.

How were Roche Holding AG’s earnings last quarter?

Roche Holding AG released its earnings results on Jul 24, 2025. The company reported CHF11.08 earnings per share for the quarter, beating the consensus estimate of CHF10.77 by CHF0.31.

Is Roche Holding AG overvalued?

According to Wall Street analysts Roche Holding AG’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Roche Holding AG pay dividends?

Roche Holding AG pays a Annually dividend of CHF9.7 which represents an annual dividend yield of 3.59%. See more information on Roche Holding AG dividends here

What is Roche Holding AG’s EPS estimate?

Roche Holding AG’s EPS estimate is 8.58.

How many shares outstanding does Roche Holding AG have?

Roche Holding AG has 702,562,700 shares outstanding.

What happened to Roche Holding AG’s price movement after its last earnings report?

Roche Holding AG reported an EPS of CHF11.08 in its last earnings report, beating expectations of CHF10.77. Following the earnings report the stock price went up 1.454%.

Which hedge fund is a major shareholder of Roche Holding AG?

Currently, no hedge funds are holding shares in CH:ROG

Company Description

Roche Holding AG

Roche Holding AG is a global leader in healthcare, specializing in pharmaceuticals and diagnostics. Founded in 1896 and headquartered in Basel, Switzerland, Roche operates in two main divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals division focuses on innovative medicines in areas such as oncology, immunology, infectious diseases, ophthalmology, and neuroscience, while the Diagnostics division develops and provides a wide range of clinical laboratory products, point-of-care testing, and molecular diagnostics. Roche is renowned for its commitment to research and development, driving advancements in personalized healthcare and innovative treatment solutions.

Roche Holding AG (ROG) Earnings & Revenues

Historic Earnings Reports

ROG Company Deck

ROG Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The call highlighted strong growth in pharmaceutical sales and robust pipeline development, particularly in oncology and neurology. However, challenges in the Diagnostics segment due to China's pricing reforms and mixed clinical trial results tempered the positive outlook. Additionally, regulatory setbacks and geopolitical uncertainties added caution.View all CH:ROG earnings summaries

ROG Stock 12 Month Forecast

Average Price Target

CHF271.45

▲(0.50% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"230":"CHF230","289":"CHF289","348":"CHF348","259.5":"CHF259.5","318.5":"CHF318.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":347.423160775383,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF347.42</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":271.4513348022,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF271.45</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":231.615440516922,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF231.62</span>\n  </div></div>","useHTML":true}}],"tickPositions":[230,259.5,289,318.5,348],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,260.2,266.9094739057987,273.61894781159737,280.32842171739605,287.03789562319474,293.74736952899343,300.4568434347922,307.1663173405908,313.87579124638955,320.58526515218824,327.29473905798693,334.0042129637856,340.7136868695843,{"y":347.423160775383,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,260.2,261.0654872924769,261.93097458495384,262.7964618774308,263.6619491699077,264.5274364623846,265.39292375486156,266.2584110473384,267.12389833981536,267.9893856322923,268.8548729247692,269.72036021724614,270.58584750972307,{"y":271.4513348022,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,260.2,258.0011877320709,255.80237546414185,253.60356319621278,251.40475092828368,249.2059386603546,247.00712639242553,244.80831412449646,242.6095018565674,240.41068958863832,238.21187732070922,236.01306505278015,233.81425278485108,{"y":231.615440516922,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":278.489,"date":1725148800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":256.516,"date":1727740800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":264.357,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 17</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":247.998,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":247.32,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":276.844,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 19</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":289.621,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":292.4,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":269.3,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":264.7,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":260.7,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":257.1,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":260.2,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >